In our study, we documented that in the memory-like NK cells from healthy donors and cancer patients, there is an increase in the expression of the NCRs, NKp30, NKp44 and NKp46 superior to that induced by treatment with IL-2 alone in the control NK cells. This evidence concerns the gene NCR1 and cancer.